As of 2025-09-17, the Relative Valuation of Neogenomics Inc (NEO) is (21.50) USD. This relative valuation is based on P/E multiples. With the latest stock price at 7.99 USD, the upside of Neogenomics Inc based on Relative Valuation is -369.1%.
The range of the Relative Valuation is (21.62) - (21.20) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 26.8x - 31.3x | 29.3x |
| Forward P/E multiples | 22.2x - 26.3x | 24.1x |
| Fair Price | (21.62) - (21.20) | (21.50) |
| Upside | -370.5% - -365.3% | -369.1% |
| Date | P/E |
| 2025-09-16 | -9.92 |
| 2025-09-15 | -10.03 |
| 2025-09-12 | -9.88 |
| 2025-09-11 | -10.36 |
| 2025-09-10 | -9.29 |
| 2025-09-09 | -9.76 |
| 2025-09-08 | -9.85 |
| 2025-09-05 | -9.91 |
| 2025-09-04 | -10.01 |
| 2025-09-03 | -10.17 |
| 2025-09-02 | -10.94 |
| 2025-08-29 | -10.90 |
| 2025-08-28 | -8.95 |
| 2025-08-27 | -8.79 |
| 2025-08-26 | -8.32 |
| 2025-08-25 | -8.01 |
| 2025-08-22 | -8.20 |
| 2025-08-21 | -7.67 |
| 2025-08-20 | -7.57 |
| 2025-08-19 | -7.83 |
| 2025-08-18 | -7.75 |
| 2025-08-15 | -7.71 |
| 2025-08-14 | -7.70 |
| 2025-08-13 | -7.75 |
| 2025-08-12 | -7.55 |
| 2025-08-11 | -7.23 |
| 2025-08-08 | -7.20 |
| 2025-08-07 | -7.15 |
| 2025-08-06 | -6.82 |
| 2025-08-05 | -6.98 |
| 2025-08-04 | -7.04 |
| 2025-08-01 | -6.41 |
| 2025-07-31 | -6.01 |
| 2025-07-30 | -6.33 |
| 2025-07-29 | -6.52 |
| 2025-07-28 | -8.02 |
| 2025-07-25 | -7.81 |
| 2025-07-24 | -7.97 |
| 2025-07-23 | -8.21 |
| 2025-07-22 | -7.97 |
| 2025-07-21 | -7.71 |
| 2025-07-18 | -7.75 |
| 2025-07-17 | -8.34 |
| 2025-07-16 | -8.58 |
| 2025-07-15 | -8.57 |
| 2025-07-14 | -8.92 |
| 2025-07-11 | -9.01 |
| 2025-07-10 | -9.30 |
| 2025-07-09 | -9.35 |
| 2025-07-08 | -9.25 |